Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain.
NCT ID: NCT07130812
Last Updated: 2025-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2025-09-29
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is Low-load Resistance Training With Blood Flow Restriction More Effective Than Traditional Rehabilitation of Military Personnel With Lower Limb Injuries
NCT06621953
Effects of a Lower Back Wrap Device on Lower Back Pain, Physical Function, and Quality of Life
NCT06749912
Kettlebell Swings & Low Back Pressure Pain Threshold
NCT03696615
Aquatic and Land Exercises for Chronic Low Back Pain
NCT06874881
The Effect of ESWT Added to Conservative Treatment on Pain, Disability, and Ultrasonographic Outcomes in Chronic Low Back Pain
NCT07132762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood Flow Restriction Group
Using blood flow restriction, participants partake in aerobic (rowing) and anaerobic (squats/deadlifts) exercises.
blood flow restriction
The SAGA blood flow restriction tourniquet system will be used for each training sessions for the rowers within the light load restriction group. The 4 inch-wide tourniquet will be applied to both upper thighs during the strength and endurance exercises. Tourniquet setting will be determined as the pressure needed to achieve 40-80% arterial occlusion to the extremity (as measured by the SAGA BFR unit). The SAGA units provides a consistent amount of pressure to the extremity throughout the ROM of the exercise. The settings will be determined at baseline and then recalibrated weekly.
Non Blood Flow Restriction Group
Participants partake in aerobic and anaerobic exercises without blood flow restrictions. The participants will use heavier loads in the anaerobic exercises.
Heavy load resistance training
For the resistance prescription, rowers will do strengthening exercises at 70-80% 1 RM. Exercises will be performed in series following 6 sets by 5 reps, with 120 seconds of rest between sets for each exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood flow restriction
The SAGA blood flow restriction tourniquet system will be used for each training sessions for the rowers within the light load restriction group. The 4 inch-wide tourniquet will be applied to both upper thighs during the strength and endurance exercises. Tourniquet setting will be determined as the pressure needed to achieve 40-80% arterial occlusion to the extremity (as measured by the SAGA BFR unit). The SAGA units provides a consistent amount of pressure to the extremity throughout the ROM of the exercise. The settings will be determined at baseline and then recalibrated weekly.
Heavy load resistance training
For the resistance prescription, rowers will do strengthening exercises at 70-80% 1 RM. Exercises will be performed in series following 6 sets by 5 reps, with 120 seconds of rest between sets for each exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently active rower (training ≥3 days/week or 12 hours/week)
* Mild LBP with a low reactivity (\<3/10) or recurring LBP within the past 18 months that has affected attendance to team practices/races.
* Able to complete a 2,000-meter rowing erg test
Exclusion Criteria
* History of spinal surgery or structural spine conditions (scoliosis requiring bracing/surgery)
* Have a contraindication to BFR training, identified via BFR safety screening form:
* Peripheral vascular disease (PVD)
* History of vascular surgery in arms or legs
* Skin grafts on arms or legs
* Arteriovenous fistula in limbs
* Cognitive or physical impairment that limits participation
* Hypertension or high blood pressure (uncontrolled or undiagnosed)
* Bleeding disorders (e.g., hemophilia)
* Blood clotting disorders (e.g., lupus, factor-V Leiden)
* Past history of DVT or pulmonary embolism (PE)
* Surgery in the past 12 weeks
* Recent limb immobilization (e.g., cast, boot) in the last 4 weeks
* History of stroke or transient ischemic attack (TIA)
* History of cancer
* Diagnosed heart disease
* History of rhabdomyolysis
* Diagnosed diabetes
* Sickle cell disease
* History of compartment syndrome
* History of nerve damage or injury
* Any prior complications or adverse reactions to BFR training
* Any other medical conditions that should be cleared by a physician before starting BFR
* Pregnancy(Self-reported)
13 Years
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Loma Linda University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Everett Lohman
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Everett Lohman, Dsc
Role: PRINCIPAL_INVESTIGATOR
Loma Linda University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University
Loma Linda, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5250411
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.